204 related articles for article (PubMed ID: 7674530)
1. Clozapine treatment of schizophrenia.
Pickar D; Hsiao JK
JAMA; 1995 Sep; 274(12):981-3. PubMed ID: 7674530
[No Abstract] [Full Text] [Related]
2. Clozapine and dopamine D(2) blockade.
Pilowsky LS; Ell PJ
Am J Psychiatry; 2002 Feb; 159(2):324-5. PubMed ID: 11823296
[No Abstract] [Full Text] [Related]
3. Positron emission tomography of in-vivo binding characteristics of atypical antipsychotic drugs. Review of D2 and 5-HT2 receptor occupancy studies and clinical response.
Nyberg S; Nakashima Y; Nordström AL; Halldin C; Farde L
Br J Psychiatry Suppl; 1996 May; (29):40-4. PubMed ID: 8733822
[No Abstract] [Full Text] [Related]
4. Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia.
Pilowsky LS; Costa DC; Ell PJ; Murray RM; Verhoeff NP; Kerwin RW
Lancet; 1992 Jul; 340(8813):199-202. PubMed ID: 1353135
[TBL] [Abstract][Full Text] [Related]
5. A new framework for investigating antipsychotic action in humans: lessons from PET imaging.
Kapur S
Mol Psychiatry; 1998 Mar; 3(2):135-40. PubMed ID: 9577837
[TBL] [Abstract][Full Text] [Related]
6. Schizophrenia.
Freedman R
N Engl J Med; 2003 Oct; 349(18):1738-49. PubMed ID: 14585943
[No Abstract] [Full Text] [Related]
7. No support for regional selectivity in clozapine-treated patients: a PET study with [(11)C]raclopride and [(11)C]FLB 457.
Talvik M; Nordström AL; Nyberg S; Olsson H; Halldin C; Farde L
Am J Psychiatry; 2001 Jun; 158(6):926-30. PubMed ID: 11384901
[TBL] [Abstract][Full Text] [Related]
8. Schizophrenia: an illness of distorted reality.
Dean B
Biologist (London); 2000 Sep; 47(4):202-6. PubMed ID: 11153121
[TBL] [Abstract][Full Text] [Related]
9. Extrastriatal and striatal D(2) dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia.
Xiberas X; Martinot JL; Mallet L; Artiges E; Loc'H C; Mazière B; Paillère-Martinot ML
Br J Psychiatry; 2001 Dec; 179():503-8. PubMed ID: 11731352
[TBL] [Abstract][Full Text] [Related]
10. Dopamine D4 receptors: a new opportunity for research on schizophrenia.
Liégeois J; Eyrolles L; Bruhwyler J; Delarge J
Curr Med Chem; 1998 Apr; 5(2):77-100. PubMed ID: 9481035
[TBL] [Abstract][Full Text] [Related]
11. The D2 receptor: love it and leave it.
Pickar D
Mol Psychiatry; 1998 Mar; 3(2):101-2. PubMed ID: 9577830
[No Abstract] [Full Text] [Related]
12. Positron emission tomography finding of a high striatal D2 receptor occupancy in olanzapine-treated patients.
Nordström AL; Nyberg S; Olsson H; Farde L
Arch Gen Psychiatry; 1998 Mar; 55(3):283-4. PubMed ID: 9510228
[No Abstract] [Full Text] [Related]
13. Dopamine D(2) receptor blockade in schizophrenia.
Bressan RA; Jones HM; Ell PJ; Pilowsky LS
Am J Psychiatry; 2001 Jun; 158(6):971-2. PubMed ID: 11384924
[No Abstract] [Full Text] [Related]
14. Dopamine D2 and D4 receptor ligands: relation to antipsychotic action.
Wilson JM; Sanyal S; Van Tol HH
Eur J Pharmacol; 1998 Jun; 351(3):273-86. PubMed ID: 9721018
[TBL] [Abstract][Full Text] [Related]
15. Schizophrenia: The drug deadlock.
Abbott A
Nature; 2010 Nov; 468(7321):158-9. PubMed ID: 21068804
[No Abstract] [Full Text] [Related]
16. Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism.
Vauquelin G; Bostoen S; Vanderheyden P; Seeman P
Naunyn Schmiedebergs Arch Pharmacol; 2012 Apr; 385(4):337-72. PubMed ID: 22331262
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D2 receptor occupancy in vivo and response to the new antipsychotic risperidone.
Busatto GF; Pilowsky LS; Ell PJ; Costa DC; Verhoeff NP; Kerwin RW
Br J Psychiatry; 1993 Dec; 163():833-4. PubMed ID: 7508329
[No Abstract] [Full Text] [Related]
18. [123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics.
Klemm E; Grünwald F; Kasper S; Menzel C; Broich K; Danos P; Reichmann K; Krappel C; Rieker O; Briele B; Hotze AL; Möller HJ; Biersack HJ
Am J Psychiatry; 1996 Feb; 153(2):183-90. PubMed ID: 8561197
[TBL] [Abstract][Full Text] [Related]
19. The relationship between risperidone plasma levels and dopamine D2 occupancy: a positron emission tomographic study.
Remington G; Kapur S; Zipursky R
J Clin Psychopharmacol; 1998 Feb; 18(1):82-3. PubMed ID: 9472848
[No Abstract] [Full Text] [Related]
20. Instrumentally detected changes in motor functioning in patients with low levels of antipsychotic dopamine D2 blockade.
Fitzgerald PB; Kapur S; Caligiuri MP; Jones C; Silvestri S; Remington G; Zipursky RB
Neuropsychopharmacology; 2000 Jan; 22(1):19-26. PubMed ID: 10633487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
